Related references
Note: Only part of the references are listed.Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1
C. L. Gorter de Vries et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U. Lin et al.
LANCET ONCOLOGY (2015)
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
Azeem Saleem et al.
EJNMMI RESEARCH (2015)
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
I. E. Krop et al.
ANNALS OF ONCOLOGY (2015)
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
Aki Morikawa et al.
NEURO-ONCOLOGY (2015)
Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab
Muhammet Ali Kaplan et al.
BREAST CANCER (2015)
Breast cancer brain metastases responding to primary systemic therapy with T-DM1
Rupert Bartsch et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema
Julie A. Carlson et al.
NEURO-ONCOLOGY (2014)
Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases
Antoine-Laurent Braccini et al.
BMC CANCER (2013)
Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies
Antoine Laurent Braccini et al.
BREAST (2013)
A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients
Hiroji Iwata et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
Brain metastases free survival differs between breast cancer subtypes
A. Berghoff et al.
BRITISH JOURNAL OF CANCER (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy
Renata Duchnowska et al.
ONCOLOGIST (2012)
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
Nancy U. Lin et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study
William Jacot et al.
BMC CANCER (2010)
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Nancy U. Lin et al.
CLINICAL CANCER RESEARCH (2009)
Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
Makiko Ono et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment and prognosis of brain metastases from breast cancer
Kazuhiko Ogawa et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier
Hans-Joachim Stemmler et al.
ANTI-CANCER DRUGS (2007)
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
T Yau et al.
ACTA ONCOLOGICA (2006)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Survival after brain metastases from breast cancer in the trastuzumab era
DG Kirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
JC Bendell et al.
CANCER (2003)
Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging
A Hutter et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2003)
Share Paper
